Karyopharm Therapeutics Inc.·4

Sep 5, 4:29 PM ET

Mano Michael 4

4 · Karyopharm Therapeutics Inc. · Filed Sep 5, 2023

Insider Transaction Report

Form 4
Period: 2023-09-01
Mano Michael
EVP, CLO&Secretary
Transactions
  • Sale

    Common Stock

    2023-09-01$1.33/sh3,888$5,176142,234 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION